文献速递治疗药物监测与药物基因组学抗菌药物管理

β-内酰胺类治疗药物监测项目的实施:大型学术医疗中心经验

Implementation of a β-lactam therapeutic drug monitoring program: Experience from a large academic medical center.
PubMed 文献 · Am J Health Syst Pharm · 2022-01-01

该文描述佛罗里达大学Shands医院2015年建立的β-内酰胺类治疗药物监测(BL-TDM)项目的实施与运行。对1438例患者首次BL-TDM分析显示,最常见监测药物为头孢吡肟(61%)、哌拉西林(15%)和美罗培南(11%);在可获取MIC和谷浓度的患者中88%达到100% fT>MIC的PK/PD目标,25%患者据此调整剂量。

要点

  • BL-TDM由药师主导、多部门协作,覆盖全院患者区域。
  • 头孢吡肟、哌拉西林和美罗培南是最常监测的β-内酰胺类药物。
  • BL-TDM使25%患者实现剂量调整,助力达到PK/PD目标。

核心结论

  • BL-TDM项目实施需医生、药师、护理、采血及分析实验室人员协同努力。
  • 标准抗菌药物给药未能使所有患者达到最佳PK/PD目标,BL-TDM使每4例患者中1例调整剂量。

研究设计与样本

  • 佛罗里达大学Shands医院于2015年建立BL-TDM项目,为药师主导的会诊服务,覆盖所有患者护理区域。
  • 对1438例患者首次BL-TDM会诊进行分析。

主要发现

  • BL-TDM最常用于头孢吡肟(61%,n=882)、哌拉西林(15%,n=218)和美罗培南(11%,n=151)。
  • BL-TDM在β-内酰胺类启动后中位3天(四分位距1-5天)进行。
  • 在可获取MIC值和谷浓度的患者中,100% fT>MIC的PK/PD目标在308例患者(88%)中达到。
  • BL-TDM导致25%(n=361)患者进行剂量调整。

临床怎么用

  • 对住院患者尤其是药代动力学改变者,可开展BL-TDM以优化药物浓度,兼顾疗效与毒性。
  • BL-TDM服务宜由药师主导、多部门协作,覆盖全院。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To describe the implementation and operationalization of a β-lactam (BL) therapeutic drug monitoring (TDM) program at a large academic center. SUMMARY: BLs are the most used class of antibiotics. Suboptimal antibiotic exposure is a significant concern in hospitalized patients, particularly in those with altered pharmacokinetics. BL-TDM provides clinicians the opportunity to optimize drug concentrations to ensure maximal therapeutic efficacy while minimizing toxicity. However, BL-TDM has not been widely adopted due to the lack of access to assays. The University of Florida Shands Hospital developed a BL-TDM program in 2015. This is a consultative service primarily run by pharmacists and is conducted in all patient care areas. An analysis was performed on the first BL-TDM encounter for 1,438 patients. BL-TDM was most frequently performed for cefepime (61%, n = 882), piperacillin (15%, n = 218), and meropenem (11%, n = 151). BL-TDM was performed a median of 3 days (interquartile range, 1-5 days) from BL initiation. Among patients with available minimum inhibitory concentration (MIC) values and trough concentrations, the pharmacokinetic/pharmacodynamic (PK/PD) target of 100% fT>MIC was attained in 308 patients (88%). BL-TDM resulted in a dosage adjustment in 25% (n = 361) of patients. CONCLUSION: Implementation of a BL-TDM program requires the concerted efforts of physicians, pharmacists, nursing staff, phlebotomists, and personnel in the analytical laboratory. Standard antibiotic dosing failed to achieve optimal PK/PD targets in all patients; utilizing BL-TDM, dose adjustments were made in 1 of every 4 patients.

来源:Am J Health Syst Pharm,查看原文。版权归原作者所有。

引用

  1. Venugopalan V, Hamza M, Santevecchi B, et al. Implementation of a β-lactam therapeutic drug monitoring program: Experience from a large academic medical center. Am J Health Syst Pharm. 2022. PMID: 35704702. doi:10.1093/ajhp/zxac171

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。